Gts Securities LLC Annovis Bio, Inc. Transaction History
Gts Securities LLC
- $45.4 Billion
- Q3 2024
A detailed history of Gts Securities LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 40,200 shares of ANVS stock, worth $227,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,200Holding current value
$227,532% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ANVS
# of Institutions
46Shares Held
1.17MCall Options Held
229KPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA380KShares$2.15 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il103KShares$581,2360.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$570,0120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.1KShares$560,9850.0% of portfolio
-
Group One Trading, L.P. Chicago, IL52.8KShares$298,6610.02% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $46.2M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...